HIGHLIGHTS
- who: Clara Esnault and collaborators from the Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Chambray-les-Tours, France have published the article: Antibody-Drug Conjugates as an Emerging Therapy in Oncodermatology, in the Journal: Cancers 2022, 14, 778. of /2022/
- what: After providing an overview of ADC design and development the goal of this article is to review the potential ADC indications in the field of oncodermatology. iations.
SUMMARY
In both cases, i.e., extra- and intracellular proteins, the specificity of the tumor antigen, antigen expression levels and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.